Open Access
This journal is a peer reviewed, fully open access journal owned by FAR Publishing Limited. FAR Publishing Limited retains copyright of the overall compiled journal and the compiled issues. The article is universally and freely accessible via the internet in perpetuity, in an easily readable format immediately after publication.
To provide open access, this journal has an open access fee (also known as an Article Processing Charge, APC) which needs to be paid by the authors or on their behalf e.g. by their research funder or institution. The open access publication fee for this journal is USD 2100, plus taxes.
It should be noted that authors who submit manuscripts to this journal agree by default that they will pay the open access fee after the manuscript is accepted.
Article Publishing Charge (APC)
As an open access journal with no subscription charges, a fee (Article Publishing Charge, APC) is payable by the authors, or their institution or funders, to cover the costs associated with publication. This ensures your article will be immediately and permanently free to access by everyone.
Authors are required to pay an Article Publishing Charge (APC) of 2100 US dollars to cover the expenses associated with the publication process. As an open access journal, we do not impose any subscription fees. This APC ensures that your article will be immediately and permanently available to the global research community and the public at no cost.
-
Taxes and Transaction Fees:
Local Value Added Tax (VAT) or local tax will be added if applicable.
Credit card companies may charge a transaction fee of 4%–5%.
-
Criteria for Full Waiver:
APC waivers are available for authors who are not financially supported or whose institutions lack sufficient funds for open access publication. Priority is given to authors from low-income countries/regions (as defined by the World Bank and/or other international organizations). This policy is based on the fact that all authors listed in the manuscript (not just the corresponding author) are from low-income countries. Additionally, the research must be conducted in these regions or primarily focus on topics relevant to these areas. Each research team is eligible for a maximum of one APC waiver per year, with given preference to scholars in the greatest need to ensure more researchers have the opportunity to receive funding.
-
Discounts:
We may offer discounts of 10% to 40% to authors who are members of affiliated societies. If your research institution or funding agency supports open-access publishing but your project is underfunded, you may also apply for a discount.
Please note that before submitting your manuscript, you are requested to send an email to cpa@fargroups.com to apply for a discount or a waiver.
We offer two payment methods: Bank Transfer and online payment. The invoice and the link for online payment will be sent by noreply@fargroups.com. Please note that, in order not to delay the publication process, the APC should be paid within 5 working days. This journal will not issue any refunds in any form after accepting the manuscript.
Refund Policy
This refund policy outlines the terms and conditions under which refunds or credits may be issued for articles published in our journals.
Once an article has been submitted into the publication workflow, APCs (Article Processing Charge) are deemed non-refundable. Nonetheless, should an oversight by our publication team result in the article's failure to be published, the editorial board retains the right to approve a refund on a case-by-case basis.
We recommend that you carefully review these conditions prior to submitting your manuscript for publication.
Peer review under the responsibility of Editorial Board of Current Pharmaceutical Analysis.
Access Rights
All articles published open access will be immediately and permanently free for everyone to read, download, copy and distribute.
User Rights
A CC user license manages the reuse of the article. Articles will be published under following license:
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND):
Allows users to copy and distribute the Article, provided this is not done for commercial purposes and further does not permit distribution of the Article if it is changed or edited in any way, and provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, and that the licensor is not represented as endorsing the use made of the work. The full details of the license are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.
Creative Commons Attribution 4.0 (CC-BY)
Let others to copy, to create extracts, abstracts and new works from the Article, to alter and revise the Article, and to make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work. The full details of the license are available at https://creativecommons.org/licenses/by/4.0/
Author Rights
For open access publishing, this journal uses a licensing agreement. For the single article, Authors will retain copyright alongside scholarly usage rights, and KeAi Communications Co., Ltd. and FAR Publishing Limited will be granted non-exclusive publishing and distribution rights.
Publishing Schedule
The journal is planning for 9 issues in 2025, with 10 issues scheduled for 2026.
Learn More about:
Contact Detail
Jerry Xu
Managing Editor
Email: jerry_xu@fargroups.com
